Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has issued a corrigendum to its 32nd Annual General Meeting (AGM) Notice and Annual Report for FY 2024-25, which was originally submitted to BSE on September 8, 2025. The corrigendum fixes a typographical error in the Record Date for determining shareholder entitlement to the dividend for FY ending March 31, 2025. The Record Date has been corrected from Saturday, September 13, 2025 to Thursday, September 18, 2025. Shareholders are advised to read this correction along with the original AGM Notice and Annual Report.
This is purely an administrative correction and does not change any business decision, financial result, or dividend amount. Shareholders who were eligible under the original date remain eligible; the Record Date for dividend entitlement is now September 18, 2025, giving investors a few extra days to hold the stock and qualify for the dividend.